Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): A cross-sectional study in over 500 patients

BJU International

Volumn 110, Issue 11, 2012, Pages 1642-1647

  Turkbey, Baris ^a   Huang, Robert ^a   Vourganti, Srinivas ^a   Trivedi, Hari ^a   Bernardo, Marcelino ^a   Yan, Pingkun ^b   Benjamin, Compton ^a   Pinto, Peter A ^a   Choyke, Peter L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b XI AN INSTITUTE OF OPTICS AND PRECISION MECHANICS   (China)

Author keywords

age related changes; BPH; MRI; prostate zonal volumes

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGE; AGED; ARTICLE; CENTRAL PROSTATE GLAND VOLUME; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE ZONAL VOLUME; PROSTATECTOMY; SCORING SYSTEM; SEXUAL HEALTH INVENTORY FOR MEN; WHOLE PROSTATE VOLUME;

EID: 84870872741     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11469.x     Document Type: Article

References (21)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL,. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474-9
2. Oesterling JE, Jacobsen SJ, Chute CG, et al,. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA 1993; 270: 860-4
3. Roehrborn CG, Lee M, Meehan A, Waldstreicher J, PLESS Study Group. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. Urology 2003; 62: 894-9
4. Jacobsen SJ, Jacobson DJ, Girman CJ, et al,. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997; 158: 481-7
5. Roberts RO, Jacobsen SJ, Jacobson DJ, Rhodes T, Girman CJ, Lieber MM,. Longitudinal changes in peak urinary flow rates in a community based cohort. J Urol 2000; 163: 107-13
6. Anderson JB, Roehrborn CG, Schalken JA, Emberton M,. The progression of benign prostatic hyperplasia: examining the evidence and determining the risk. Eur Urol 2001; 39: 390-9
7. Insight Segmentation and Registration Toolkit (ITK). Insight Toolkit 3.12. Available at: http://www.itk.org/. Accessed July 2012
8. Visualization Toolkit (VTK). Visualization Toolkit 5.4.2. Available at: http://www.vtk.org/. Accessed July 2012
9. Fastlight Toolkit (FLTK). Fast Light Toolkit 1.1.9. Available at: http://www.fltk.org/. Accessed July 2012
10. Yan P, Xu S, Turkbey B, Kruecker J,. Discrete deformable model guided by partial active shape model for TRUS image segmentation. IEEE Trans Biomed Eng 2010; 57: 1158-66
11. Corica FA, Jacobsen SJ, King BF, et al,. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men. J Urol 1999; 161: 831-4
12. Hochberg DA, Armenakas NA, Fracchia JA,. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia. Prostate 2000; 45: 315-9
13. Williams AM, Simon I, Landis PK, et al,. Prostatic growth rate determined from MRI data: age-related longitudinal changes. J Androl 1999; 20: 474-80
14. Loeb S, Kettermann A, Carter HB, Ferrucci L, Metter EJ, Walsh PC,. Prostate volume changes over time: results from the Baltimore Longitudinal Study of Aging. J Urol 2009; 182: 1458-62
15. Rhodes T, Girman CJ, Jacobsen SJ, Roberts RO, Guess HA, Lieber MM,. Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol 1999; 161: 1174-9
16. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E,. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16
17. Collins GN, Lee RJ, McKelvie GB, Rogers AC, Hehir M,. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993; 71: 445-50
18. Oesterling JE,. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907-23
19. Kaplan SA, Te AE, Pressler LB, Olsson CA,. Transition zone index as a method of assessing benign prostatic hyperplasia: correlation with symptoms, urine flow and detrusor pressure. J Urol 1995; 154: 1764-9
20. Girman CJ, Jacobsen SJ, Guess HA, et al,. Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol 1995; 153: 1510-5
21. St Sauver JL, Jacobson DJ, Girman CJ, McGree ME, Lieber MM, Jacobsen SJ,. Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort. Eur Urol 2006; 50: 105-11